During the call, it was discussed that the company was

New Post Public Reply Private Reply Replies (3) Message Board
sunclouds generactor #43088
757
During the call, it was discussed that the company was expecting to have the question about how the rest of the mono patients at 700mg faired in the trial, they just assumed it would be during the review process.

While it would have been hard to provide this data in April/May when the trial data was being submitted, it is much easier now since the last patient finished their 1 year treatment in June.

NP has consistently said that the FDA is being helpful and adapting processes to facilitate their review and potential approval. NP is proactively praising the FDA, if he wasn’t happy with them he could simply say nothing.

By talking about the FDA positively I believe he is addressing all the FDA conspiracy theorists that appear here and elsewhere.

I choose to believe the viewpoint of the CEO and CRO lead on the combo trial who have all the info rather that the host of FDA haters here most of who have probably never interacted with the FDA much less worked In the industry.

To further emphasize my point, when the company has been unhappy within the FDA, they say it - remember when Jay L complained about how long it took to get the first COVID trial approved because they did not understand how Leronlimab would work. In addition they continue to question the effectiveness of Remdesivir which we all know the FDA approved for EUA.

There does not seem to be concern from the company on the HIV front and I think we all should trust the opinion of our leaders who have all the info on this but i realize that some people will probably never change their opinion because the FDA is a good scapegoat and most have never worked in a pharma company so this is an area they are not very knowledgeable.

IMO

CytoDyn Inc (CYDY) Stock Research Links

CYDY Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

AI-Driven Lumi Transforms Car Dealership Interactions

Updated Category News Views 8

Lumi: Changing the Car Buying Game Picture this: You're browsing for a new car, head filled with specifics like towing capacity, price points, and trim options. Usually, such queries would send you bouncing around the web, but Lectrium's Lumi promises to keep the questioning—and decision-making—right on the dealership's page. In a move set to shake up the game,...

Continue Reading
Sean Trahan Joins Citrin Cooperman: New Tax Lead

Updated Category News Views 8

Citrin Cooperman's Strategic Tax Move If there's one phrase that can spark a debate at a financial water cooler, it's 'transfer pricing.' Today, Citrin Cooperman is throwing its hat further into that ring with the appointment of Sean Trahan as head of their new Transfer Pricing and Value Chain Optimization Practice. This isn't just another reshuffling of office...

Continue Reading
Machine Grabs Prime Dallas Property Amid Apartment Boom

Updated Category News Views 7

Dallas' Hot Market and Machine's Bold Move Well, well, looks like Machine Investment Group's been busy flexing its real estate muscles, bagging a 490-unit gem in North Dallas—your typical, no-frills off-market grab. We’re talking 75 West, nestled in a juicy infill spot, and it’s catching eyes like gold dust in a pan. You don't need me to tell you North Dallas ain't...

Continue Reading
HTX's Strategic Moves in Pakistan: A Crypto Frontier

Updated Category News Views 6

Paving the Way: HTX's Journey in Pakistan Rolling into the Pakistan cryptocurrency scene isn't just a 'walk in the park' for HTX—it's more like traversing a new frontier with an open map. This isn’t some hit-and-run operation; HTX is strategizing for a long haul in one of the liveliest digital market arenas in South Asia. Gathering steam with community AMAs and an X...

Continue Reading
FJBio Boosts Antibody Discovery with Sapio AI

Updated Category News Views 5

In the sprawling world of antibody discovery, where every scrap of data can make or break the next big breakthrough, FairJourney Bio (FJBio) is pulling out all the stops. They've teamed up with Sapio Sciences to ditch the paperwork nightmares and usher in a new era of AI-driven efficiency. With operations stretching from Porto to Cambridge to sunny San Diego, they’re...

Continue Reading
Dr. Desi Bartlett Teams Up with Glo for Perimenopause Focus

Updated Category News Views 4

Glo Taps Top Wellness Expert for Women's Health Initiative In an industry brimming with wellness voices, it's rare to find one that marries scholarly acumen with authentic, personal teaching. Yet, this is precisely what Dr. Desi Bartlett brings to the table as she partners with Glo to offer new fitness programming specifically targeting women facing perimenopause and...

Continue Reading
Cracking the Code of America's Delivery Addiction

Updated Category News Views 4

America's New Obsession: Convenience at a Cost Diving into the relentless hustle, Americans are shelling out big bucks to dodge life's mundane chores. A fresh survey dished out by FinanceBuzz, hitching a ride with Bank of America, gives us a peek into how hooked everyone is on convenience services like food and grocery deliveries. It’s clear people are ready to fork...

Continue Reading
FutureVault's AI Agents: Transforming Financial Workflows

Updated Category News Views 4

Revolutionizing Financial Operations: FutureVault's AI Approach In the dizzying whirlwind of financial services, the launch of FutureVault AI Agents is a game-changer for document management. This isn't some half-baked tool; it's a full-fledged overhaul of how compliance and operations should tick in the modern age. We've all seen it—a paper trail tangled across systems...

Continue Reading
Succession Planning in Turmoil: Only 42% Ready

Updated Category News Views 5

Diving into the Succession Crisis in Finance Succession planning in the financial advisory space is like retirement planning for the rest of us—everyone knows it's crucial, yet too many put it off. Despite the looming retirement wave and desperate interest from the younger cohort, a staggering 42% of financial advisors are still without a documented succession game...

Continue Reading
K-Beauty Takes Front Stage at Target Beauty Studio

Updated Category News Views 5

Making Waves in the U.S. with K-Beauty SUNGBOON EDITOR and Milk Touch just rolled into Target Beauty Studio, making a splash in the world of K-beauty. From ingredients that boast serious benefits to playful cosmetics that let you express yourself, these brands are shaking up American beauty routines in a big way. Ingredient-Focused Skincare for Every American Face...

Continue Reading

Top 5 Most Recently Viewed Articles

Easterly ROCMuni Bond Fund Investors Alert: Legal Action Ahead

Updated Category News Views 144

Critical Alert for Investors in Easterly ROCMuni Bond Fund Attention investors! There’s an important deadline approaching concerning legal actions related to the Easterly ROCMuni High Income Municipal Bond Fund. If you have experienced losses, now is the time to stay informed and act. Understanding the Situation Recently, the Easterly ROCMuni High Income Municipal Bond...

Continue Reading
Veralto Declares Consistent Quarterly Dividend for Investors

Updated Category News Views 51

Veralto's Quarterly Dividend Announcement Veralto (NYSE: VLTO), a leading name in water and product quality solutions, has announced a quarterly dividend of $0.09 per share. This decision underscores Veralto's unwavering commitment to its shareholders and its ongoing financial health. Understanding Dividend Payments Dividends often indicate a company's financial...

Continue Reading
BioLineRx Sees Growth in Pipeline and Financial Resilience

Updated Category News Views 133

BioLineRx Continues to Build Momentum with Financial Stability BioLineRx Ltd. (NASDAQ: BLRX), a prominent biopharmaceutical company dedicated to advancing treatments in oncology and rare diseases, has reported robust financial results and significant progress in its operational endeavors. The company is pursuing new innovative avenues for pipeline expansion while ensuring...

Continue Reading
Blues Expands Partner Network to Enhance IoT Solutions

Updated Category News Views 35

Blues Expands Its Partnership Network Recently, the Blues Partner Network has marked a significant milestone by welcoming more than fifty accredited partners. This innovative initiative focuses on easing the connections between sensors and the analytics solutions essential for various businesses. The advantages brought by Blues' products streamline how devices connect to...

Continue Reading
Lamarr.AI Secures $1.1 Million to Enhance Building Solutions

Updated Category News Views 57

Lamarr.AI Secures $1.1 Million to Improve Building Solutions Lamarr.AI has recently garnered substantial attention, raising $1.1 million in a pre-seed funding round aimed at advancing their innovative building diagnostics technology. Supported by notable investors, including Hazelview Ventures, milemark·capital, and Newlab, Lamarr.AI is positioning itself as a leader in...

Continue Reading